Person

Guy Marks

Recently added resources

Report

5 May 2015
235

This report describes patterns of dispensing of respiratory medications in Australia through detailed analyses of Pharmaceutical Benefits Scheme data, as well as other sources, to draw inferences about respiratory medication use among patients with asthma and chronic obstructive pulmonary disease.

Summary

This...

Report

20 Nov 2013
136

This report outlines a proposed approach to monitoring access to, and utilisation of, pulmonary rehabilitation and long term oxygen therapy, by capitalising on existing data sources and identifying data development opportunities.

Summary

Chronic obstructive pulmonary disease (COPD) is a major cause of...

Report

12 Sep 2013
68

This report outlines a proposed approach to monitoring asthma during pregnancy by capitalising on existing data sources as well as identifying data development opportunities.

Summary

Pregnant women with poorly controlled asthma are at increased risk of experiencing pregnancy-induced hypertension and pre-eclampsia. They...

Report

18 Sep 2009
80

In 2003 asthma was the leading cause of burden of disease in Australian children, contributing 17.4% of total DALYs and the eleventh-leading contributor to the overall burden of disease in Australia, accounting for 2.4% of the total number of DALYs. Asthma also contributed a substantial...

Report

10 May 2007
26

Drug therapy is the cornerstone of treatment for controlling asthma and preventing and relieving attacks. This report describes the first study to use national data from the Pharmaceutical Benefits Scheme (PBS) to investigate the patterns of asthma medication use in Australia. It examines the effects...

Items authored 6